This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Aug;4(8):e323-e324.

doi: 10.1016/S2352-3018(17)30087-5. Epub 2017 May 8.

Resistance matters in EARNEST

Gary Maartens¹, Graeme Meintjes²

Affiliations

Affiliations

¹ Department of Medicine, University of Cape Town Health Sciences Faculty, Cape Town 7925, South Africa. Electronic address: gary.maartens@uct.ac.za.
² Department of Medicine, University of Cape Town Health Sciences Faculty, Cape Town 7925, South Africa.

PMID: 28495563
DOI: 10.1016/S2352-3018(17)30087-5

Free article

Comment

Resistance matters in EARNEST

Gary Maartens et al. Lancet HIV. 2017 Aug.

Free article

. 2017 Aug;4(8):e323-e324.

doi: 10.1016/S2352-3018(17)30087-5. Epub 2017 May 8.

Authors

Gary Maartens¹, Graeme Meintjes²

Affiliations

¹ Department of Medicine, University of Cape Town Health Sciences Faculty, Cape Town 7925, South Africa. Electronic address: gary.maartens@uct.ac.za.
² Department of Medicine, University of Cape Town Health Sciences Faculty, Cape Town 7925, South Africa.

PMID: 28495563
DOI: 10.1016/S2352-3018(17)30087-5

No abstract available

PubMed Disclaimer

Comment on

Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial.
Paton NI, Kityo C, Thompson J, Nankya I, Bagenda L, Hoppe A, Hakim J, Kambugu A, van Oosterhout JJ, Kiconco M, Bertagnolio S, Easterbrook PJ, Mugyenyi P, Walker AS; Europe Africa Research Network for Evaluation of Second-line Therapy (EARNEST) Trial Team. Paton NI, et al. Lancet HIV. 2017 Aug;4(8):e341-e348. doi: 10.1016/S2352-3018(17)30065-6. Epub 2017 May 8. Lancet HIV. 2017. PMID: 28495562 Free PMC article.

Similar articles

The importance of being earnest. Specific advantages and new treatment options for the un-undetectable.
Berger DS. Berger DS. Posit Aware. 2007 Mar-Apr;18(2):37. Posit Aware. 2007. PMID: 17390490 No abstract available.
Why HIV drug resistance matters: an overview.
Learned J. Learned J. Posit Aware. 2005 Sep-Oct;16(5):26-30. Posit Aware. 2005. PMID: 16220604 No abstract available.
Rapid matters: POCT for HIV.
Nascimento A. Nascimento A. MLO Med Lab Obs. 2014 Mar;46(3):12. MLO Med Lab Obs. 2014. PMID: 24696947 No abstract available.
Congruence matters: a consideration of adaptation and appropriateness.
Temoshok LR. Temoshok LR. Adv Mind Body Med. 2003 Summer;19(2):10-2. Adv Mind Body Med. 2003. PMID: 14579801 Review. No abstract available.
[Practice and needs of Swiss physicians in matters of prevention of HIV infection in their office--experience, reflections and recommendations].
Meystre-Agustoni G, Dubois-Arber F, Grüninger U, Cassis I, Jeannin A. Meystre-Agustoni G, et al. Schweiz Med Wochenschr. 1995 Apr 1;125(13):621-6. Schweiz Med Wochenschr. 1995. PMID: 7709177 Review. French.

See all similar articles

Cited by

Virologic outcomes on dolutegravir-, atazanavir-, or efavirenz-based ART in urban Zimbabwe: A longitudinal study.
Shamu T, Egger M, Mudzviti T, Chimbetete C, Manasa J, Anderegg N. Shamu T, et al. PLoS One. 2024 Feb 23;19(2):e0293162. doi: 10.1371/journal.pone.0293162. eCollection 2024. PLoS One. 2024. PMID: 38394297 Free PMC article.
Continuation of emtricitabine/lamivudine within combination antiretroviral therapy following detection of the M184V/I HIV-1 resistance mutation.
Stirrup OT, Asboe D, Pozniak A, Sabin CA, Gilson R, Mackie NE, Tostevin A, Hill T, Dunn DT; UK HIV Drug Resistance Database and the UK Collaborative HIV Cohort. Stirrup OT, et al. HIV Med. 2020 May;21(5):309-321. doi: 10.1111/hiv.12829. Epub 2020 Jan 11. HIV Med. 2020. PMID: 31927793 Free PMC article.
Viral suppression among children and their caregivers living with HIV in western Kenya.
Humphrey JM, Genberg BL, Keter A, Musick B, Apondi E, Gardner A, Hogan JW, Wools-Kaloustian K. Humphrey JM, et al. J Int AIDS Soc. 2019 Apr;22(4):e25272. doi: 10.1002/jia2.25272. J Int AIDS Soc. 2019. PMID: 30983148 Free PMC article.
Effectiveness of Protease Inhibitor/Nucleos(t)ide Reverse Transcriptase Inhibitor-Based Second-line Antiretroviral Therapy for the Treatment of Human Immunodeficiency Virus Type 1 Infection in Sub-Saharan Africa: A Systematic Review and Meta-analysis.
Stockdale AJ, Saunders MJ, Boyd MA, Bonnett LJ, Johnston V, Wandeler G, Schoffelen AF, Ciaffi L, Stafford K, Collier AC, Paton NI, Geretti AM. Stockdale AJ, et al. Clin Infect Dis. 2018 Jun 1;66(12):1846-1857. doi: 10.1093/cid/cix1108. Clin Infect Dis. 2018. PMID: 29272346 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information